TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1557484

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3901650

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 31111798

Group type: EXPERIMENTAL
Intervention: Brief cognitive-behavioural therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 30115826

Group type: EXPERIMENTAL
Intervention: Whole grain rye kernel-based bread (RKB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: White wheat flour-based bread (WWB)
Number of subjects: 0
Study: 27132053

Group type: EXPERIMENTAL
Intervention: Outpatient hysteroscopy
Number of subjects: 702

Group type: COMPARATOR
Intervention: No hysteroscopy (control group)
Number of subjects: 702
Study: 25716546

Group type: EXPERIMENTAL
Intervention: TOF group (targeted to maintain two counts of train‐of‐four (TOF))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T1 group (maintain the T1/Tc ratio at 50%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: N group (no relaxants after tracheal intubation)
Number of subjects: 0
Study: 22762867

Group type: EXPERIMENTAL
Intervention: Inhalation of tobramycin inhalation solution (TIS) for 28 days
Number of subjects: 58

Group type: COMPARATOR
Intervention: Inhaled sodium colistimethate (2×2 millU/day) plus oral ciprofloxacin (30 mg/kg/day) for 3 months (CC)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Inhaled sodium colistimethate (CC) for 3 months
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both treatments (TIS and CC)
Number of subjects: 58
Study: 20304396

Group type: EXPERIMENTAL
Intervention: DJBL
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 47
Study: 18978107

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 364

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 364
Study: 15671222

Group type: EXPERIMENTAL
Intervention: Calcium intake (dietary and supplemental)
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Vitamin D intake (dietary and supplemental)
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Supplemental calcium and vitamin D use during follow-up
Number of subjects: 1905
Study: 12662005

Group type: EXPERIMENTAL
Intervention: Rifampicin plus ethambutol
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Rifampicin, ethambutol and isoniazid
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 106
Study: 10485302

Group type: EXPERIMENTAL
Intervention: Dual-chamber syringe (n = 213)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Separate injections (n = 215)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Single manually reconstituted injection (n = 59)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: All groups (PRP-T and DTP-IPV)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Dual-chamber syringe and separate injection methods
Number of subjects: 487
Study: 8602666

Group type: EXPERIMENTAL
Intervention: Neostigmine (5, 10, 20, and 50 micrograms x kg(‐1))
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Edrophonium (100, 200, 400, and 1,000 micrograms x kg(‐1))
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Spontaneous recovery
Number of subjects: 108
Study: 2016625

Group type: EXPERIMENTAL
Intervention: FAMTX (methotrexate, fluorouracil, doxorubicin)
Number of subjects: 213

Group type: COMPARATOR
Intervention: FAM (fluorouracil, doxorubicin, mitomycin)
Number of subjects: 213
Study: 7006539

Group type: EXPERIMENTAL
Intervention: Ibuprofen (Motrin)
Number of subjects: 15
Study: 31870658

Group type: EXPERIMENTAL
Intervention: Fatigue protocol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham fatigue protocol
Number of subjects: 40
Study: 31060834

Group type: EXPERIMENTAL
Intervention: Mixed meals with 11 ml extra virgin olive oil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mixed meals without extra virgin olive oil
Number of subjects: 20
Study: 27911049

Group type: EXPERIMENTAL
Intervention: 20-week special intervention (SI)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Delayed intervention (DI)
Number of subjects: 108
Study: 26431847

Group type: EXPERIMENTAL
Intervention: Evidence-Based Medicine (EBM) program including a roundtable seminar on Depot Medroxy Progesterone Acetate (DMPA) and two 15 min one-on-one educational visits.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified, but implied as those not receiving the EBM program.
Number of subjects: 0
Study: 24131872

Group type: EXPERIMENTAL
Intervention: Diet consultation
Number of subjects: 326

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 326
Study: 21204827

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) 600 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 25
Study: 18075754

Group type: EXPERIMENTAL
Intervention: Prototype firefighter ensemble (PE) in dry conditions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard ensemble (SE) in dry conditions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prototype firefighter ensemble (PE) in wet conditions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard ensemble (SE) in wet conditions
Number of subjects: 8
Study: 17062050

Group type: EXPERIMENTAL
Intervention: Terbinafine 1% FFS
Number of subjects: 273

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study: 12965315

Group type: EXPERIMENTAL
Intervention: Thoracoscopic T3‐4 sympathicotomy
Number of subjects: 262
Study: 11196420

Group type: EXPERIMENTAL
Intervention: DHEA (50 mg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1541612

Group type: EXPERIMENTAL
Intervention: Operative treatment (12 immediate and 3 delayed)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-steroidal anti-inflammatory medications
Number of subjects: 24
Study: 3895963

Group type: EXPERIMENTAL
Intervention: Clotrimazole 500 mg single-dose treatment
Number of subjects: 103

Group type: COMPARATOR
Intervention: Clotrimazole 200 mg 3-day treatment
Number of subjects: 103
Study: 30707661

Group type: EXPERIMENTAL
Intervention: Alisertib 50 mg two times per day (days 1 to 7; 21-day cycle)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Investigator-selected single-agent comparator (including intravenous pralatrexate 30 mg/m2 once per week for 6 weeks; intravenous gemcitabine 1,000 mg/m2; or intravenous romidepsin 14 mg/m2 days 1, 8, and 15; 28-day cycle)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Alisertib
Number of subjects: 271

Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 271
Study: 29223355

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 32
Study: 26012547

Group type: EXPERIMENTAL
Intervention: Knee arthroscopy
Number of subjects: 4096

Group type: EXPERIMENTAL
Intervention: Preoperative radiological assessment
Number of subjects: 4096
Study: 23406475

Group type: EXPERIMENTAL
Intervention: Descriptive norm
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Injunctive norm
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study: 22356118

Group type: EXPERIMENTAL
Intervention: Olanzapine monotherapy (5-20 mg/day)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Olanzapine with mood stabilizer (lithium, carbamazepine, or valproate)
Number of subjects: 139
Study: 20585710

Group type: EXPERIMENTAL
Intervention: Modified Robert‐Jones bandage for 24 hours
Number of subjects: 2

Group type: COMPARATOR
Intervention: No bandage (Control)
Number of subjects: 2
Study: 18339043

Group type: EXPERIMENTAL
Intervention: Tear lubricant (Refresh Soothe and Protect)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Saline (Chauvin Pharmaceuticals Ltd)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no additional eye drops)
Number of subjects: 18
Study: 15750379

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study: 11796654

Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 21

Group type: COMPARATOR
Intervention: Boys vs. Men
Number of subjects: 21
Study: 10595868

Group type: EXPERIMENTAL
Intervention: Stavudine-containing triple therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stavudine-containing combination therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 0
Study: 8706777

Group type: EXPERIMENTAL
Intervention: Quinidine 200 mg given 2 hours before codeine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no quinidine)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Quinidine 200 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Quinidine pre-treatment
Number of subjects: 17
Study: 1535302

Group type: EXPERIMENTAL
Intervention: Citalopram (40 mg/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 6380205

Group type: EXPERIMENTAL
Intervention: Bromhexine (Bisolvon) 48 mg daily for 3 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 31603721

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Corticosteroid injection (Control)
Number of subjects: 115
Study: 29186529

Group type: EXPERIMENTAL
Intervention: DAV132 coadministration with moxifloxacin
Number of subjects: 28

Group type: COMPARATOR
Intervention: DAV132 alone
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nonactive substitute
Number of subjects: 28
Study: 26843120

Group type: EXPERIMENTAL
Intervention: Red ginseng (5 g daily for 12 weeks)
Number of subjects: 62
Study: 25259743

Group type: EXPERIMENTAL
Intervention: Paricalcitol (2 μg/d for 12 weeks)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 88
Study: 22187085

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 26

Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups (Prone and Supine)
Number of subjects: 26
Study: 20067641

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans GBI‐30, 6086
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 17469680

Group type: EXPERIMENTAL
Intervention: New drug (not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard agent (not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16096515

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12324797

Group type: EXPERIMENTAL
Intervention: LMSRT
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: FRIACOM
Number of subjects: 14
Study: 10414756

Group type: EXPERIMENTAL
Intervention: Moderate-intensity step aerobics training (50% of peak oxygen uptake) for 12 weeks, progressing to 100 minutes per week of step aerobics and 50 minutes per week of cycling
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no training program)
Number of subjects: 26
Study: 7594425

Group type: EXPERIMENTAL
Intervention: Cyclosporin (5 mg/kg twice a day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2064591

Group type: EXPERIMENTAL
Intervention: Local hyperthermia in addition to radical radiation (Group II)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Radical radiation only (Group I)
Number of subjects: 50
Study: 6195240

Group type: EXPERIMENTAL
Intervention: 1 g latamoxef
Number of subjects: 236

Group type: COMPARATOR
Intervention: 1 g cephaloridine
Number of subjects: 236
Study: 31865134

Group type: EXPERIMENTAL
Intervention: Early AED withdrawal (discontinued at one year post-surgery)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Late AED withdrawal (continued on single AED for three years before discontinuation)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Early AED withdrawal
Number of subjects: 135

Group type: COMPARATOR
Intervention: Late AED withdrawal
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 135
Study: 31292457

Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 29977328

Group type: EXPERIMENTAL
Intervention: Open abdomen (OA) management with application of an active negative peritoneal pressure therapy (ANPPT) dressing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formal closure of the fascia
Number of subjects: 0
Study: 26884588

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with cisplatin, paclitaxel, cetuximab ± everolimus
Number of subjects: 94
Study: 25139226

Group type: EXPERIMENTAL
Intervention: Periodontal dressing group (PDG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CG, non-placement of periodontal dressing)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 22951888

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 2993

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2993

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 2993
Study: 19651582

Group type: EXPERIMENTAL
Intervention: Modular procedural skills curriculum for pediatric residents during intern orientation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual methods of learning procedural skills (Control)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Modular procedural skills curriculum for pediatric residents
Number of subjects: 38
Study: 17497548

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Assessment-only
Number of subjects: 30
Study: 16320677

Group type: EXPERIMENTAL
Intervention: Emoxipine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Reamberin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mexidol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 12081777

Group type: EXPERIMENTAL
Intervention: Modified Thiersch‐Duplay urethroplasty (group A)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Parameatal based flip‐flap Mathieu hypospadias repair (group B)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 381
Study: 9854662

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA) regimen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard analgesic regimen
Number of subjects: 60
Study: 7611214

Group type: EXPERIMENTAL
Intervention: Interferon alfa-n3 therapy
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Platelet transfusion, intravenous steroids, and intravenous immunoglobulin
Number of subjects: 1
Study: 2225703

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg every 6 hours
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7000219

Group type: EXPERIMENTAL
Intervention: iotroxamide
Number of subjects: 200

Group type: COMPARATOR
Intervention: iogylcamide
Number of subjects: 200
Study: 31332665

Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB) diagnosed atypical papillary neoplasms (PN)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB) diagnosed papillary neoplasms (PN) with concurrent atypical ductal hyperplasia
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB) diagnosed papillary neoplasms (PN) with concurrent atypical lobular hyperplasia/flat epithelial atypia
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB) diagnosed non-atypical papillary neoplasms (PN)
Number of subjects: 317
Study: 27960614

Group type: EXPERIMENTAL
Intervention: Long-term individual shear rate therapy (ISRT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Short-term individual shear rate therapy (ISRT)
Number of subjects: 14
Study: 26183582

Group type: EXPERIMENTAL
Intervention: Individual music therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 17
Study: 23383603

Group type: EXPERIMENTAL
Intervention: Pancreatin 25,000 minimicrospheres (Creon 25000 MMS); 9-15 capsules/day (3 with main meals, 2 with snacks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Pancreatin 25,000 minimicrospheres (Creon 25000 MMS) during open-label extension
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Pancreatin 25,000 minimicrospheres (Creon 25000 MMS)
Number of subjects: 58
Study: 21879368

Group type: EXPERIMENTAL
Intervention: Homeless adults
Number of subjects: 247
Study: 19249017

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT) delivered in addition to treatment-as-usual (TAU)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) alone
Number of subjects: 28
Study: 17310045

Group type: COMPARATOR
Intervention: tiotropium plus placebo
Number of subjects: 449

Group type: COMPARATOR
Intervention: tiotropium plus salmeterol
Number of subjects: 449

Group type: COMPARATOR
Intervention: tiotropium plus fluticasone-salmeterol
Number of subjects: 449
Study: 15204372

Group type: EXPERIMENTAL
Intervention: Bell-and-pad (alarm) system for 12 weeks
Number of subjects: 28
Study: 11261404

Group type: EXPERIMENTAL
Intervention: Induced negative mood
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulating the stop rules for catastrophizing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mood as input hypothesis
Number of subjects: 0
Study: 9586892

Group type: EXPERIMENTAL
Intervention: 17-1A antibody (900 mg total: 500 mg postoperatively followed by 4 monthly doses of 100 mg)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 189
Study: 7988180

Group type: EXPERIMENTAL
Intervention: Terbutaline (bolus, 0.25 mg; maintenance dose, 5 micrograms/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3054048

Group type: EXPERIMENTAL
Intervention: Modified Widman flap combined with citric acid demineralization and autologous fibronectin application
Number of subjects: 29

Group type: COMPARATOR
Intervention: Modified Widman flap alone
Number of subjects: 29
Study: 4925508

Group type: EXPERIMENTAL
Intervention: 10% N-acetylcysteine plus isoproterenol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10% 2-mercaptoethane sulphonate plus isoproterenol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control aerosol of saline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control aerosol of saline plus isoproterenol
Number of subjects: 12
Study: 31645423

Group type: COMPARATOR
Intervention: Cisplatin-paclitaxel plus bevacizumab (control arm)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Cisplatin-paclitaxel plus bevacizumab plus atezolizumab (experimental arm)
Number of subjects: 404
Study: 30979632

Group type: EXPERIMENTAL
Intervention: Hydrolyzed rice-protein formulas (HRPFs)
Number of subjects: 0
Study: 28294936

Group type: EXPERIMENTAL
Intervention: Serve at least two vegetables with dinner meals
Number of subjects: 39

Group type: COMPARATOR
Intervention: Pair vegetables with other foods the child likes
Number of subjects: 39

Group type: COMPARATOR
Intervention: Eat dinner together with an adult(s) modelling vegetable consumption
Number of subjects: 39
Study: 25196580

Group type: EXPERIMENTAL
Intervention: Pumpkin seed (5 g b.i.d.)
Number of subjects: 1431

Group type: EXPERIMENTAL
Intervention: Pumpkin seed extract (500 mg b.i.d.)
Number of subjects: 1431

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1431
Study: 23333088

Group type: EXPERIMENTAL
Intervention: n-3 PUFA (2.090 g of EPA and 1.165 g of DHA)
Number of subjects: 109

Group type: COMPARATOR
Intervention: High-oleic-acid sunflower oil (placebo)
Number of subjects: 109
Study: 21274882

Group type: EXPERIMENTAL
Intervention: rcHIP/PAP
Number of subjects: 100
Study: 18463627

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg infused over 30 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 8
Study: 16581488

Group type: EXPERIMENTAL
Intervention: On-pump operation (cardiopulmonary bypass)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Off-pump operation (no cardiopulmonary bypass)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study: 12646793

Group type: EXPERIMENTAL
Intervention: Oxymetholone TID (150 mg/day)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Oxymetholone BID (100 mg/day)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 10646814

Group type: EXPERIMENTAL
Intervention: GnRH‐a/hMG
Number of subjects: 161

Group type: COMPARATOR
Intervention: hMG only
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: One AIH
Number of subjects: 161

Group type: COMPARATOR
Intervention: Two AIHs
Number of subjects: 161
Study: 9346145

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (group therapy)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (individual therapy)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (15-hour program)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (30-hour program)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (60-hour program)
Number of subjects: 84
Study: 8445454

Group type: EXPERIMENTAL
Intervention: Depressed plasma fibronectin levels
Number of subjects: 17
Study: 3524463

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy plus immunotherapy with N-CWS and irradiated allogeneic AML cells
Number of subjects: 73

Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 73
Study: 28691316

Group type: EXPERIMENTAL
Intervention: Unwaxed dental floss impregnated with 2% chlorhexidine (used twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard unwaxed dental floss (used twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Negative control (no interproximal cleaning)
Number of subjects: 30